Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue
+5.52%
EPS
+258.4%
Free cash flow
−7.81%
Total debt
+47.1%

Quarter to September 2026, against a year earlier

335.98 3.70 −1.09%
Market cap
$64.8B
P/E
18.8×
Fwd P/E
17.5×
Dividend yield
0.71%
F-score
7/9
Altman Z
n/a
Beneish M
−2.59
Dividend safety
70/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
7 7 6 6

+8 more TTM periods

ROE
0.00% 96.34% 106.98% 132.25%
ROA
4.26% 3.33% 3.33% 2.20%
ROIC
24.40% 15.65% 12.64% 20.29%
Return on Tangible Assets
(391.32%) (256.39%) (1,370.54%) (64.24%)
Average Days of Receivables
28.49 27.91 27.64 29.11
Free Cash Flow per Share
20.34 21.26 8.23 18.79
Free Cash Flow
3,880.67 4,105.92 1,601.89 3,650.33
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026